AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
What is the latest Total Current Liabilities ratio of AJANTA PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹996 Cr |
| Mar2024 | ₹895 Cr |
| Mar2023 | ₹1,139 Cr |
| Mar2022 | ₹647 Cr |
| Mar2021 | ₹839 Cr |
How is Total Current Liabilities of AJANTA PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹996 Cr | 11.27 | |
| Mar2024 | ₹895 Cr | -21.42 | |
| Mar2023 | ₹1,139 Cr | 75.98 | |
| Mar2022 | ₹647 Cr | -22.82 | |
| Mar2021 | ₹839 Cr | - | |
Compare Total Current Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹37,731.7 Cr | -0.8% | 3.5% | 17.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.8% |
3.5% |
17.3% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses